Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michela Pasello

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Cancers|April 12, 2022
miR-214-3p Is Commonly Downregulated by EWS-FLI1 and by CD99 and Its Restoration Limits Ewing Sarcoma AggressivenessAlessandra De Feo, Laura Pazzaglia, Lisa Ciuffarin, et al.
Genes, Chromosomes & Cancer|December 24, 2008
Mechanisms of gene amplification and evidence of coamplification in drug-resistant human osteosarcoma cell linesClaudia M Hattinger, Giuseppina Stoico, Francesca Michelacci, et al.
International Journal of Oncology|November 8, 2006
May P-glycoprotein status be used to stratify high-grade osteosarcoma patients? Results from the Italian/Scandinavian Sarcoma Group 1 treatment protocolMassimo Serra, Michela Pasello, Maria Cristina Manara, et al.
Molecular Biosystems|November 10, 2011
Targeting GSTP1-1 induces JNK activation and leads to apoptosis in cisplatin-sensitive and -resistant human osteosarcoma cell linesAndrea Sau, Giuseppe Filomeni, Silvia Pezzola, et al.
European Journal of Cancer (Oxford, England : 1990)|May 26, 2005
Prognostic and therapeutic relevance of HER2 expression in osteosarcoma and Ewing's sarcomaKatia Scotlandi, Maria C Manara, Claudia M Hattinger, et al.
Journal of Cell Communication and Signaling|November 11, 2024
CD99 contributes to the EWS::FLI1 transcriptome by specifically affecting FOXM1-targets involved in the G2/M cell cycle phase, thus influencing the Ewing sarcoma genetic landscapeMichela Pasello, Maria Antonella Laginestra, Maria Cristina Manara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2018
Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 is a Novel Post-Transcriptional Regulator of Ewing Sarcoma MalignancyCaterina Mancarella, Michela Pasello, Selena Ventura, et al.
European Journal of Cell Biology|October 30, 2003
Genomic imbalances associated with methotrexate resistance in human osteosarcoma cell lines detected by comparative genomic hybridization-based techniquesClaudia M Hattinger, Gemma Reverter-Branchat, Daniel Remondini, et al.
Oncotarget|November 12, 2016
CD99 triggering induces methuosis of Ewing sarcoma cells through IGF-1R/RAS/Rac1 signalingMaria Cristina Manara, Mario Terracciano, Caterina Mancarella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2009
Effect of TP53 Arg72Pro and MDM2 SNP309 polymorphisms on the risk of high-grade osteosarcoma development and survivalGiuseppe Toffoli, Paola Biason, Antonio Russo, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Cancers|April 12, 2022
miR-214-3p Is Commonly Downregulated by EWS-FLI1 and by CD99 and Its Restoration Limits Ewing Sarcoma AggressivenessAlessandra De Feo, Laura Pazzaglia, Lisa Ciuffarin, et al.
Genes, Chromosomes & Cancer|December 24, 2008
Mechanisms of gene amplification and evidence of coamplification in drug-resistant human osteosarcoma cell linesClaudia M Hattinger, Giuseppina Stoico, Francesca Michelacci, et al.
International Journal of Oncology|November 8, 2006
May P-glycoprotein status be used to stratify high-grade osteosarcoma patients? Results from the Italian/Scandinavian Sarcoma Group 1 treatment protocolMassimo Serra, Michela Pasello, Maria Cristina Manara, et al.
Molecular Biosystems|November 10, 2011
Targeting GSTP1-1 induces JNK activation and leads to apoptosis in cisplatin-sensitive and -resistant human osteosarcoma cell linesAndrea Sau, Giuseppe Filomeni, Silvia Pezzola, et al.
European Journal of Cancer (Oxford, England : 1990)|May 26, 2005
Prognostic and therapeutic relevance of HER2 expression in osteosarcoma and Ewing's sarcomaKatia Scotlandi, Maria C Manara, Claudia M Hattinger, et al.
Journal of Cell Communication and Signaling|November 11, 2024
CD99 contributes to the EWS::FLI1 transcriptome by specifically affecting FOXM1-targets involved in the G2/M cell cycle phase, thus influencing the Ewing sarcoma genetic landscapeMichela Pasello, Maria Antonella Laginestra, Maria Cristina Manara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2018
Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 is a Novel Post-Transcriptional Regulator of Ewing Sarcoma MalignancyCaterina Mancarella, Michela Pasello, Selena Ventura, et al.
European Journal of Cell Biology|October 30, 2003
Genomic imbalances associated with methotrexate resistance in human osteosarcoma cell lines detected by comparative genomic hybridization-based techniquesClaudia M Hattinger, Gemma Reverter-Branchat, Daniel Remondini, et al.
Oncotarget|November 12, 2016
CD99 triggering induces methuosis of Ewing sarcoma cells through IGF-1R/RAS/Rac1 signalingMaria Cristina Manara, Mario Terracciano, Caterina Mancarella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2009
Effect of TP53 Arg72Pro and MDM2 SNP309 polymorphisms on the risk of high-grade osteosarcoma development and survivalGiuseppe Toffoli, Paola Biason, Antonio Russo, et al.
Pageof 5